MEDBRIDGE-Guided Support for Type 2 Diabetes Patients
This study is testing a support program called MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention. It aims to help adults with type 2 diabetes (T2D) manage their medications after leaving the hospital. The program involves a nurse case manager (NCM) and a community health worker (CHW) who use a computer tool called MEDBRIDGE to identify patients at high risk for problems after discharge. The study wants to see if this support helps patients with their medication adherence and care transition. To join, you must be 18 or older, have type 2 diabetes (HbA1c of 6.5% or higher), and have been discharged from UAB Hospital or its emergency departments, receiving primary care at specific clinics. The study is currently unclear on its recruitment status.
- Study design
- This is a single-arm feasibility pilot study, meaning all 45 participants will receive the MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention. It is not specified if participants will be blinded to the intervention.
- What's involved
- Participants will receive a 3-month post-discharge care coordination intervention. This includes an initial contact after discharge to review medications and ongoing monthly check-ins by a community health worker.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures retention rate at 3 months post-enrollment and patient acceptability at the end of the 3-month intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Seung-Yup Lee, PhD · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Recruitment Rate6-month recruitment window
Number of patient enrollments per month compared against threshold of 6 enrollments per month. Enrollment rate calculated as the percentage of eligible patients (based on MEDBRIDGE recommendations) who enrolled in the intervention (completed first interaction); target 50% or higher.
- Retention Rate3 months post-enrollment
Percentage of enrolled patients completing each round of the intervention (first, second, and up to the final round). Target completion rate of 60% or higher. Estimated 85% retention per subsequent interaction, yielding approximately 61% final retention.
- Patient AcceptabilityEnd of 3-month intervention
Patient scores on the Acceptability of Intervention Measure (AIM), assessed using a 5-point Likert scale. Target mean score of 4 or higher. Surveys assess comfort with the intervention process and communication with the NCM/CHW team.
- Intervention FidelityThroughout 3-month intervention
NCM/CHW self-report logs including interaction start and end timestamps and a checklist of core intervention components performed, compared against adherence threshold of 0.85. Bi-weekly supervision sessions review logs to ensure protocol adherence.